Continuity of medication management in Medicaid patients with chronic comorbid conditions: An examination by mental health status

Joel F. Farley, Richard A. Hansen, Marisa E. Domino, Mrudula Borse, Nirosha Mahendraratnam, Neepa Ray, Matthew L. Maciejewski

Research output: Contribution to journalArticle

Abstract

Objective Patients with serious mental illness (SMI) often have comorbid cardiometabolic conditions (CMCs) that may increase the number of prescribers involved in treatment. This study examined whether patients with SMI (depression and schizophrenia) and comorbid CMCs experience greater discontinuity of prescribing than patients with CMCs alone. Methods 2009 Medicaid data were used to compare number and types of prescribers (primary care, cardiometabolic, psychiatric, other) in individuals with 1–3 CMCs (diabetes, hypertension, dyslipidemia) alone (n = 76.451); with CMC and schizophrenia (n = 6507); and with CMC and depression (n = 23.510) and the degree of prescribing within a provider's area of specialty. Results 44%, 61%, and 71% of individuals with CMCs only, with CMCs and schizophrenia, and with CMCs and depression had medications from these classes prescribed by 5 or more providers respectively. > 35% of patients with CMCs alone or CMCs and schizophrenia had prescriptions provided by 3 or more PCP providers, which increased to 49.1% for patients with CMCs and depression. In the schizophrenia cohort, 29% of antipsychotics were PCP-prescribed while psychiatrists prescribed 10%, 9%, and 9% of antihypertensive, antihyperlipidemic, and antidiabetic medications respectively. Conclusions The presence of SMI increases the number of prescribers treating individuals with CMCs. The impact of this fragmentation in medication management on health outcomes is unknown.

LanguageEnglish (US)
Pages25-31
Number of pages7
JournalGeneral Hospital Psychiatry
Volume45
DOIs
StatePublished - Mar 1 2017

Fingerprint

Medicaid
Health Status
Schizophrenia
Mental Health
Depression
Psychiatry
Hypolipidemic Agents
Dyslipidemias
Hypoglycemic Agents
Antihypertensive Agents
Antipsychotic Agents
Prescriptions
Primary Health Care
Hypertension
Health

Keywords

  • Chronic disease
  • Continuity of care
  • Diabetes
  • Hypertension
  • Mental health

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Continuity of medication management in Medicaid patients with chronic comorbid conditions : An examination by mental health status. / Farley, Joel F.; Hansen, Richard A.; Domino, Marisa E.; Borse, Mrudula; Mahendraratnam, Nirosha; Ray, Neepa; Maciejewski, Matthew L.

In: General Hospital Psychiatry, Vol. 45, 01.03.2017, p. 25-31.

Research output: Contribution to journalArticle

Farley, Joel F. ; Hansen, Richard A. ; Domino, Marisa E. ; Borse, Mrudula ; Mahendraratnam, Nirosha ; Ray, Neepa ; Maciejewski, Matthew L./ Continuity of medication management in Medicaid patients with chronic comorbid conditions : An examination by mental health status. In: General Hospital Psychiatry. 2017 ; Vol. 45. pp. 25-31
@article{ac9764de99de4473872577cc0351cc60,
title = "Continuity of medication management in Medicaid patients with chronic comorbid conditions: An examination by mental health status",
abstract = "Objective Patients with serious mental illness (SMI) often have comorbid cardiometabolic conditions (CMCs) that may increase the number of prescribers involved in treatment. This study examined whether patients with SMI (depression and schizophrenia) and comorbid CMCs experience greater discontinuity of prescribing than patients with CMCs alone. Methods 2009 Medicaid data were used to compare number and types of prescribers (primary care, cardiometabolic, psychiatric, other) in individuals with 1–3 CMCs (diabetes, hypertension, dyslipidemia) alone (n = 76.451); with CMC and schizophrenia (n = 6507); and with CMC and depression (n = 23.510) and the degree of prescribing within a provider's area of specialty. Results 44{\%}, 61{\%}, and 71{\%} of individuals with CMCs only, with CMCs and schizophrenia, and with CMCs and depression had medications from these classes prescribed by 5 or more providers respectively. > 35{\%} of patients with CMCs alone or CMCs and schizophrenia had prescriptions provided by 3 or more PCP providers, which increased to 49.1{\%} for patients with CMCs and depression. In the schizophrenia cohort, 29{\%} of antipsychotics were PCP-prescribed while psychiatrists prescribed 10{\%}, 9{\%}, and 9{\%} of antihypertensive, antihyperlipidemic, and antidiabetic medications respectively. Conclusions The presence of SMI increases the number of prescribers treating individuals with CMCs. The impact of this fragmentation in medication management on health outcomes is unknown.",
keywords = "Chronic disease, Continuity of care, Diabetes, Hypertension, Mental health",
author = "Farley, {Joel F.} and Hansen, {Richard A.} and Domino, {Marisa E.} and Mrudula Borse and Nirosha Mahendraratnam and Neepa Ray and Maciejewski, {Matthew L.}",
year = "2017",
month = "3",
day = "1",
doi = "10.1016/j.genhosppsych.2016.12.001",
language = "English (US)",
volume = "45",
pages = "25--31",
journal = "General Hospital Psychiatry",
issn = "0163-8343",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Continuity of medication management in Medicaid patients with chronic comorbid conditions

T2 - General Hospital Psychiatry

AU - Farley,Joel F.

AU - Hansen,Richard A.

AU - Domino,Marisa E.

AU - Borse,Mrudula

AU - Mahendraratnam,Nirosha

AU - Ray,Neepa

AU - Maciejewski,Matthew L.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Objective Patients with serious mental illness (SMI) often have comorbid cardiometabolic conditions (CMCs) that may increase the number of prescribers involved in treatment. This study examined whether patients with SMI (depression and schizophrenia) and comorbid CMCs experience greater discontinuity of prescribing than patients with CMCs alone. Methods 2009 Medicaid data were used to compare number and types of prescribers (primary care, cardiometabolic, psychiatric, other) in individuals with 1–3 CMCs (diabetes, hypertension, dyslipidemia) alone (n = 76.451); with CMC and schizophrenia (n = 6507); and with CMC and depression (n = 23.510) and the degree of prescribing within a provider's area of specialty. Results 44%, 61%, and 71% of individuals with CMCs only, with CMCs and schizophrenia, and with CMCs and depression had medications from these classes prescribed by 5 or more providers respectively. > 35% of patients with CMCs alone or CMCs and schizophrenia had prescriptions provided by 3 or more PCP providers, which increased to 49.1% for patients with CMCs and depression. In the schizophrenia cohort, 29% of antipsychotics were PCP-prescribed while psychiatrists prescribed 10%, 9%, and 9% of antihypertensive, antihyperlipidemic, and antidiabetic medications respectively. Conclusions The presence of SMI increases the number of prescribers treating individuals with CMCs. The impact of this fragmentation in medication management on health outcomes is unknown.

AB - Objective Patients with serious mental illness (SMI) often have comorbid cardiometabolic conditions (CMCs) that may increase the number of prescribers involved in treatment. This study examined whether patients with SMI (depression and schizophrenia) and comorbid CMCs experience greater discontinuity of prescribing than patients with CMCs alone. Methods 2009 Medicaid data were used to compare number and types of prescribers (primary care, cardiometabolic, psychiatric, other) in individuals with 1–3 CMCs (diabetes, hypertension, dyslipidemia) alone (n = 76.451); with CMC and schizophrenia (n = 6507); and with CMC and depression (n = 23.510) and the degree of prescribing within a provider's area of specialty. Results 44%, 61%, and 71% of individuals with CMCs only, with CMCs and schizophrenia, and with CMCs and depression had medications from these classes prescribed by 5 or more providers respectively. > 35% of patients with CMCs alone or CMCs and schizophrenia had prescriptions provided by 3 or more PCP providers, which increased to 49.1% for patients with CMCs and depression. In the schizophrenia cohort, 29% of antipsychotics were PCP-prescribed while psychiatrists prescribed 10%, 9%, and 9% of antihypertensive, antihyperlipidemic, and antidiabetic medications respectively. Conclusions The presence of SMI increases the number of prescribers treating individuals with CMCs. The impact of this fragmentation in medication management on health outcomes is unknown.

KW - Chronic disease

KW - Continuity of care

KW - Diabetes

KW - Hypertension

KW - Mental health

UR - http://www.scopus.com/inward/record.url?scp=85007071203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007071203&partnerID=8YFLogxK

U2 - 10.1016/j.genhosppsych.2016.12.001

DO - 10.1016/j.genhosppsych.2016.12.001

M3 - Article

VL - 45

SP - 25

EP - 31

JO - General Hospital Psychiatry

JF - General Hospital Psychiatry

SN - 0163-8343

ER -